GAO pokes holes in FDA's orphan designation process; Takeda Traditionalists make one more appeal against Shire buyout ahead of vote
→ In response to several senators’ inquiry, the Government Accountability Office has taken a closer look at how the FDA handles orphan drug designation requests …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
